Immuneering Corporation · NASDAQ:IMRX
Hall Brett Matthew bought 6,035 Immuneering Corporation shares (Form 4)
Traded Jun 15, 2026 · Filed Jun 16, 2026
On Jun 15, 2026, Hall Brett Matthew (CHIEF SCIENTIFIC OFFICER) bought 6,035 Immuneering Corporation shares at US$4.15 for US$25,045, leaving 382,531 shares. Filed Jun 16, 2026 (Form 4).
- Bought
- 6,035 shares
- Price
- US$4.15
- Value
- US$25,045
- Holding after
- 382,531 shares
- Trading plan
- No
- Role
- CHIEF SCIENTIFIC OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Class A Common Stock | Buy | 6,035 | US$4.15 | 382,531 | Direct |
Source
Related
- Immuneering Corporation
- Hall Brett Matthew
- Immuneering Corporation shareholders
- Schedule 13G · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Zeskind Benjamin J. · Jun 24, 2026
- Schedule 13G/A · Zeskind Benjamin J. · Jan 22, 2026
- Schedule 13G/A · Empery Asset Management, LP · Jan 15, 2026
- Schedule 13G · Empery Asset Management, LP · Oct 21, 2025